Frederick W Driscoll - Net Worth and Insider Trading

Frederick W Driscoll Net Worth

The estimated net worth of Frederick W Driscoll is at least $4 Million dollars as of 2024-11-08. Frederick W Driscoll is the Director of NantKwest Inc and owns about 109,235 shares of NantKwest Inc (NK) stock worth over $4 Million. Frederick W Driscoll is the CFO of Flexion Therapeutics Inc and owns about 7,777 shares of Flexion Therapeutics Inc (FLXN) stock worth over $70,926. Frederick W Driscoll is also the VP, CFO & Treasurer of Novavax Inc and owns about 1,000 shares of Novavax Inc (NVAX) stock worth over $8,935. Besides these, Frederick W Driscoll also holds MEI Pharma Inc (MEIP) , Cellectar Biosciences Inc (CLRB) . Details can be seen in Frederick W Driscoll's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frederick W Driscoll has not made any transactions after 2021-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Frederick W Driscoll

Frederick W Driscoll Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Frederick W Driscoll owns 13 companies in total, including NantKwest Inc (NK) , MEI Pharma Inc (MEIP) , and Cellectar Biosciences Inc (CLRB) among others .

Click here to see the complete history of Frederick W Driscoll’s form 4 insider trades.

Insider Ownership Summary of Frederick W Driscoll

Ticker	Comapny	Transaction Date	Type of Owner
NK	NantKwest Inc	2020-08-11	director
MEIP	MEI Pharma Inc	2021-02-23	director
CLRB	Cellectar Biosciences Inc	2021-09-03	director
		2021-01-04	director
		2019-10-23	INTERIM CFO & INTERIM TREAS
		2018-05-10	director
		2017-03-23	Chief Financial Officer
		2003-12-31	director & President and CEO
		2011-08-09	VP & CFO & Treasurer
		2017-09-18	director
		2022-03-28	Chief Financial Officer
		2022-10-13	Interim CFO
		2022-03-28	Chief Financial Officer

Frederick W Driscoll Latest Holdings Summary

Frederick W Driscoll currently owns a total of 5 stocks. Among these stocks, Frederick W Driscoll owns 109,235 shares of NantKwest Inc (NK) as of August 11, 2020, with a value of $4 Million and a weighting of 97.54%. Frederick W Driscoll owns 7,777 shares of Flexion Therapeutics Inc (FLXN) as of March 23, 2017, with a value of $70,926 and a weighting of 1.95%. Frederick W Driscoll also owns 1,000 shares of Novavax Inc (NVAX) as of August 9, 2011, with a value of $8,935 and a weighting of 0.25%. The other 2 stocks MEI Pharma Inc (MEIP) , Cellectar Biosciences Inc (CLRB) have a combined weighting of 0.27% among all his current holdings.

Latest Holdings of Frederick W Driscoll

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
NK	NantKwest Inc	2020-08-11	109,235	32.49	3,549,045
FLXN	Flexion Therapeutics Inc	2017-03-23	7,777	9.12	70,926
NVAX	Novavax Inc	2011-08-09	1,000	8.94	8,935
MEIP	MEI Pharma Inc	2021-02-23	1,875	3.06	5,738
CLRB	Cellectar Biosciences Inc	2021-09-03	1,942	2.08	4,039

Holding Weightings of Frederick W Driscoll

Frederick W Driscoll Form 4 Trading Tracker

According to the SEC Form 4 filings, Frederick W Driscoll has made a total of 1 transactions in NantKwest Inc (NK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in NantKwest Inc is the sale of 65,300 shares on August 11, 2020, which brought Frederick W Driscoll around $668,019.

According to the SEC Form 4 filings, Frederick W Driscoll has made a total of 0 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years. The most-recent trade in Flexion Therapeutics Inc is the sale of 3,000 shares on March 23, 2017, which brought Frederick W Driscoll around $69,000.

According to the SEC Form 4 filings, Frederick W Driscoll has made a total of 0 transactions in Novavax Inc (NVAX) over the past 5 years. The most-recent trade in Novavax Inc is the acquisition of 1,000 shares on August 9, 2011, which cost Frederick W Driscoll around $23,600.

More details on Frederick W Driscoll's insider transactions can be found in the Insider Trading History of Frederick W Driscoll table.

Insider Trading History of Frederick W Driscoll

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Frederick W Driscoll Trading Performance

GuruFocus tracks the stock performance after each of Frederick W Driscoll's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frederick W Driscoll is 18.39%. GuruFocus also compares Frederick W Driscoll's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frederick W Driscoll within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Frederick W Driscoll's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Frederick W Driscoll

Average Return

Average return per transaction

Outperforming Transactions

4 out of 5 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	27.06
Relative Return to S&P 500(%)	27.04

Frederick W Driscoll Ownership Network

Ownership Network List of Frederick W Driscoll

No Data

Ownership Network Relation of Frederick W Driscoll

Frederick W Driscoll Owned Company Details

What does NantKwest Inc do?

Who are the key executives at NantKwest Inc?

Frederick W Driscoll is the director of NantKwest Inc. Other key executives at NantKwest Inc include director & See remarks Barry J. Simon , Chief Financial Officer Sonja Nelson , and director & 10 percent owner & Chairman and CEO Patrick Soon-shiong .

NantKwest Inc (NK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NantKwest Inc (NK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NantKwest Inc (NK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NantKwest Inc (NK)'s detailed insider trading history can be found in Insider Trading Tracker table.

NantKwest Inc Insider Transactions

No Available Data

What does MEI Pharma Inc do?

Who are the key executives at MEI Pharma Inc?

Frederick W Driscoll is the director of MEI Pharma Inc. Other key executives at MEI Pharma Inc include Chief Medical Officer Richard G Ghalie , 10 percent owner Amin Nathoo , and 10 percent owner Funicular Funds, Lp .

MEI Pharma Inc (MEIP) Insider Trades Summary

Over the past 18 months, Frederick W Driscoll made no insider transaction in MEI Pharma Inc (MEIP). Other recent insider transactions involving MEI Pharma Inc (MEIP) include a net purchase of 201,660 shares made by Anson Funds Management Lp , and a net purchase of 134,440 shares made by Funicular Funds, Lp .

In summary, during the past 3 months, insiders sold 0 shares of MEI Pharma Inc (MEIP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MEI Pharma Inc (MEIP) were sold and 336,100 shares were bought by its insiders, resulting in a net purchase of 336,100 shares.

MEI Pharma Inc (MEIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

MEI Pharma Inc Insider Transactions

No Available Data

What does Cellectar Biosciences Inc do?

Who are the key executives at Cellectar Biosciences Inc?

Frederick W Driscoll is the director of Cellectar Biosciences Inc. Other key executives at Cellectar Biosciences Inc include Senior Vice President & Medical Andrei Shustov , Chief Commercial Officer Darrell Shane Lea , and Chief Financial Officer Chad J Kolean .

Cellectar Biosciences Inc (CLRB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cellectar Biosciences Inc (CLRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellectar Biosciences Inc (CLRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cellectar Biosciences Inc (CLRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cellectar Biosciences Inc Insider Transactions

No Available Data

What does Cue Biopharma Inc do?

Who are the key executives at Cue Biopharma Inc?

Frederick W Driscoll is the director of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include President and CSO Anish Suri , director & CEO Daniel R Passeri , and Chief Medical Officer Matteo Levisetti .

Cue Biopharma Inc (CUE) Insider Trades Summary

Over the past 18 months, Frederick W Driscoll made no insider transaction in Cue Biopharma Inc (CUE). Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net purchase of 4,000 shares made by Anish Suri , and a net purchase of 3,000 shares made by Daniel R Passeri .

In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net purchase of 7,000 shares.

Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cue Biopharma Inc Insider Transactions

No Available Data

What does Conformis Inc do?

Who are the key executives at Conformis Inc?

Frederick W Driscoll is the INTERIM CFO & INTERIM TREAS of Conformis Inc. Other key executives at Conformis Inc include Fmr Interim CFO & Controller Christine Desrochers , director & FORMER PRESIDENT & CEO Mark A Augusti , and FORMER CLO & SECRETARY Denise E Pedulla .

Conformis Inc (CFMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Conformis Inc (CFMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Conformis Inc (CFMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Conformis Inc (CFMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Conformis Inc Insider Transactions

No Available Data

What does Abpro Corp do?

Who are the key executives at Abpro Corp?

Frederick W Driscoll is the director of Abpro Corp. Other key executives at Abpro Corp include and Chief Financial Officer Adam S. Mostafa .

Abpro Corp (ABP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Abpro Corp (ABP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Abpro Corp (ABP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Abpro Corp (ABP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Abpro Corp Insider Transactions

No Available Data

What does Flexion Therapeutics Inc do?

Who are the key executives at Flexion Therapeutics Inc?

Frederick W Driscoll is the Chief Financial Officer of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , Chief Strategy Officer Christina Willwerth , and General Counsel Mark S. Levine .

Flexion Therapeutics Inc (FLXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Flexion Therapeutics Inc Insider Transactions

No Available Data

What does Oncotelic Therapeutics Inc do?

Who are the key executives at Oncotelic Therapeutics Inc?

Frederick W Driscoll is the director & President and CEO of Oncotelic Therapeutics Inc. Other key executives at Oncotelic Therapeutics Inc include CHIEF EXECUTIVE OFFICER Vuong Trieu , CHIEF BUSINESS OFFICER Saran Saund , and CHIEF FINANCIAL OFFICER Amit B. Shah .

Oncotelic Therapeutics Inc (OTLC) Insider Trades Summary

Over the past 18 months, Frederick W Driscoll made no insider transaction in Oncotelic Therapeutics Inc (OTLC). Other recent insider transactions involving Oncotelic Therapeutics Inc (OTLC) include a net purchase of 1,226,888 shares made by Vuong Trieu ,

In summary, during the past 3 months, insiders sold 0 shares of Oncotelic Therapeutics Inc (OTLC) in total and bought 500,000 shares, with a net purchase of 500,000 shares. During the past 18 months, 0 shares of Oncotelic Therapeutics Inc (OTLC) were sold and 1,226,888 shares were bought by its insiders, resulting in a net purchase of 1,226,888 shares.

Oncotelic Therapeutics Inc (OTLC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oncotelic Therapeutics Inc Insider Transactions

No Available Data

What does Novavax Inc do?

Who are the key executives at Novavax Inc?

Frederick W Driscoll is the VP & CFO & Treasurer of Novavax Inc. Other key executives at Novavax Inc include President & R&D Filip Dubovsky , President & R&D Gregory M Glenn , and EVP & Chief Strategy Officer Elaine O'hara .

Novavax Inc (NVAX) Insider Trades Summary

Over the past 18 months, Frederick W Driscoll made no insider transaction in Novavax Inc (NVAX). Other recent insider transactions involving Novavax Inc (NVAX) include a net sale of 61,216 shares made by Filip Dubovsky , and a net sale of 15,000 shares made by James F Young .

In summary, during the past 3 months, insiders sold 0 shares of Novavax Inc (NVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,216 shares of Novavax Inc (NVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 76,216 shares.

Novavax Inc (NVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Novavax Inc Insider Transactions

No Available Data

What does ImmunityBio Inc do?

Who are the key executives at ImmunityBio Inc?

Frederick W Driscoll is the director of ImmunityBio Inc. Other key executives at ImmunityBio Inc include director & 10 percent owner & See remarks Patrick Soon-shiong , 10 percent owner California Capital Equity, Llc , and 10 percent owner Nant Capital, Llc .

ImmunityBio Inc (IBRX) Insider Trades Summary

Over the past 18 months, Frederick W Driscoll made no insider transaction in ImmunityBio Inc (IBRX). Other recent insider transactions involving ImmunityBio Inc (IBRX) include a net purchase of 71,915 shares made by Michael D Blaszyk , a net purchase of 25,000 shares made by John Owen Brennan , and a net purchase of 7,000 shares made by Wesley Clark .

In summary, during the past 3 months, insiders sold 0 shares of ImmunityBio Inc (IBRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmunityBio Inc (IBRX) were sold and 103,915 shares were bought by its insiders, resulting in a net purchase of 103,915 shares.

ImmunityBio Inc (IBRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ImmunityBio Inc Insider Transactions

No Available Data

What does Renovacor Inc do?

Who are the key executives at Renovacor Inc?

Frederick W Driscoll is the Chief Financial Officer of Renovacor Inc. Other key executives at Renovacor Inc include Chief Accounting Officer Joseph S Carroll , director & Chief Executive Officer Magdalene Cook , and Chief Scientific Officer Matthew Killeen .

Renovacor Inc (RCOR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Renovacor Inc (RCOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Renovacor Inc (RCOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Renovacor Inc (RCOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Renovacor Inc Insider Transactions

No Available Data

What does Invivyd Inc do?

Who are the key executives at Invivyd Inc?

Frederick W Driscoll is the Interim CFO of Invivyd Inc. Other key executives at Invivyd Inc include director & other: See Remarks Terrance Mcguire , 10 percent owner & other: See Remarks Adimab, Llc , and Chief Financial Officer William E. Duke .

Invivyd Inc (IVVD) Insider Trades Summary

Over the past 18 months, Frederick W Driscoll made no insider transaction in Invivyd Inc (IVVD). Other recent insider transactions involving Invivyd Inc (IVVD) include a net sale of 5,000,000 shares made by Adimab, Llc , and a net sale of 112,381 shares made by Terrance Mcguire .

In summary, during the past 3 months, insiders sold 0 shares of Invivyd Inc (IVVD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,112,381 shares of Invivyd Inc (IVVD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,112,381 shares.

Invivyd Inc (IVVD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Invivyd Inc Insider Transactions

No Available Data

What does Chardan Healthcare Acquisition 2 Corp do?

Who are the key executives at Chardan Healthcare Acquisition 2 Corp?

Frederick W Driscoll is the Chief Financial Officer of Chardan Healthcare Acquisition 2 Corp. Other key executives at Chardan Healthcare Acquisition 2 Corp include Chief Accounting Officer Joseph S Carroll , director & Chief Executive Officer Magdalene Cook , and Chief Scientific Officer Matthew Killeen .

Chardan Healthcare Acquisition 2 Corp (CHAQ.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chardan Healthcare Acquisition 2 Corp (CHAQ.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chardan Healthcare Acquisition 2 Corp (CHAQ.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chardan Healthcare Acquisition 2 Corp (CHAQ.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chardan Healthcare Acquisition 2 Corp Insider Transactions

No Available Data

Frederick W Driscoll Mailing Address

Above is the net worth, insider trading, and ownership report for Frederick W Driscoll. Currently GuruFocus does not have mailing address information for Frederick W Driscoll.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.